5-[[4-[(4-fluorobenzoyl)amino]phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide
C27H25FN4O2 — CID 157308119
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[4-[(4-fluorobenzoyl)amino]phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide
5-[[4-[(4-fluorobenzoyl)amino]phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide (PubChem CID 157308119) has the molecular formula C27H25FN4O2 and a molecular weight of 456.52 g/mol. Its IUPAC name is 5-[[4-[(4-fluorobenzoyl)amino]phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide.
Molecular Properties
| Compound Name | 5-[[4-[(4-fluorobenzoyl)amino]phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide |
|---|---|
| PubChem CID | 157308119 |
| Molecular Formula | C27H25FN4O2 |
| Molecular Weight | 456.52 g/mol |
| Exact Mass | 456.20 |
| IUPAC Name | 5-[[4-[(4-fluorobenzoyl)amino]phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide |
| SMILES | Cc1ccc(CCc2n[nH]c(Cc3ccc(NC(=O)c4ccc(F)cc4)cc3)c2C(N)=O)cc1 |
| InChI | InChI=1S/C27H25FN4O2/c1-17-2-4-18(5-3-17)8-15-23-25(26(29)33)24(32-31-23)16-19-6-13-22(14-7-19)30-27(34)20-9-11-21(28)12-10-20/h2-7,9-14H,8,15-16H2,1H3,(H2,29,33)(H,30,34)(H,31,32) |
| InChIKey | PFRGWOLRAZYHJU-UHFFFAOYSA-N |
| XLogP | 4.58 |
| TPSA | 100.87 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.52 |
| LogP ≤ 5 | 4.58 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157308119 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.